Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
JCR Pharmaceuticals
Biotech
Acumen taps JCR’s brain barrier tech for $555M Alzheimer’s deal
The collaboration will involve pairing JCR’s J-Brain Cargo platform with Acumen’s amyloid beta oligomer-selective antibodies.
James Waldron
Jul 15, 2025 8:01am
Takeda’s gene therapy pivot leaves JCR behind
Dec 21, 2023 8:57am
Angelini, JCR pen epilepsy deal worth up to $505M biobucks
May 11, 2023 11:00am
